Also trades as: 4521.T (JPX) · $vol 3M

$26.00

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 46 · $984.6M mcap · 23M float · 0.0000% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$77.4B -17.7% ▼

5Y CAGR: +0.6%

Gross Profit

$39.5B -32.5% ▼

5Y CAGR: -0.7%

Operating Income

-$905M -104.3% ▼

Net Income

$2.2B -84.5% ▼

5Y CAGR: -30.6%

EPS (Diluted)

$57.52 -84.3% ▼

5Y CAGR: -30.2%

EBITDA

$2.4B -88.9% ▼

5Y CAGR: -35.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$76.0B	$73.0B	$72.0B	$94.0B	$77.4B
YoY Growth	+1.4%	-4.0%	-1.3%	+30.5%	-17.7%
Cost of Revenue	$34.5B	$33.4B	$33.5B	$35.5B	$37.9B
Gross Profit	$41.6B	$39.6B	$38.5B	$58.5B	$39.5B
Gross Margin	54.7%	54.2%	53.5%	62.2%	51.0%
R&D Expenses	$8.4B	$15.8B	$12.5B	$18.7B	$20.7B
SG&A Expenses	$15.8B	$15.5B	$16.2B	$18.5B	$19.7B
Operating Expenses	$24.5B	$31.6B	$29.0B	$37.5B	$40.4B
Operating Income	$17.1B	$8.0B	$9.5B	$21.0B	-$905M
Operating Margin	22.4%	11.0%	13.2%	22.4%	-1.2%
Interest Expense	$17M	$17M	$17M	$28M	$45M
Income Before Tax	$13.9B	$6.8B	$9.8B	$19.4B	$2.3B
Tax Expense	$4.3B	$1.4B	$1.8B	$5.5B	$169M
Net Income	$9.5B	$5.4B	$8.0B	$13.9B	$2.2B
Net Margin	12.6%	7.5%	11.1%	14.8%	2.8%
EPS (Diluted)	$251.44	$144.79	$212.66	$365.42	$57.52
EBITDA	$16.4B	$9.4B	$12.6B	$22.0B	$2.4B
Shares Outstanding	38M	38M	38M	38M	38M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$18.3B	$33.1B	$24.6B	$18.0B	$18.9B	$20.8B	$18.3B	$19.4B
Cost of Revenue	$8.2B	$9.1B	$9.5B	$8.7B	$9.0B	$8.9B	$9.0B	$10.2B
Gross Profit	$10.1B	$24.1B	$15.1B	$9.3B	$9.9B	$11.9B	$9.3B	$9.2B
Gross Margin	55.1%	72.6%	61.3%	51.8%	52.3%	57.1%	50.7%	47.6%
R&D Expenses	$3.0B	$3.0B	$4.6B	$8.2B	$5.4B	$6.4B	$4.0B	$5.0B
SG&A Expenses	$4.3B	$4.2B	$4.7B	$5.3B	$4.5B	$5.3B	$4.9B	$5.7B
Operating Expenses	$7.3B	$7.2B	$9.2B	$13.7B	$9.9B	$11.7B	$8.9B	$10.7B
Operating Income	$2.8B	$16.8B	$5.8B	-$4.4B	$14M	$192M	$352M	-$1.5B
Operating Margin	15.1%	50.8%	23.7%	-24.3%	0.1%	0.9%	1.9%	-7.6%
Interest Expense	$5M	$0	$0	$60K	$69K	$11M	$11M	$13M
Income Before Tax	$2.4B	$16.9B	$6.8B	-$6.6B	$408M	$1.0B	$588M	$331M
Tax Expense	$617M	$4.3B	$1.9B	-$1.4B	$137M	$271M	$182M	-$421M
Net Income	$1.8B	$12.5B	$4.9B	-$5.2B	$271M	$731M	$406M	$751M
Net Margin	9.6%	37.8%	19.9%	-29.0%	1.4%	3.5%	2.2%	3.9%
EPS (Diluted)	$46.32	$330.90	$129.09	$-133.99	$7.12	$19.31	$10.73	$19.17
EBITDA	$3.4B	$17.5B	$6.5B	-$3.7B	$16M	$1.9B	$1.4B	-$439M
Shares Outstanding	38M	38M	38M	39M	38M	38M	38M	38M

KKPCF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet